Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANH with iron and erythropoietin in elective myomectomy
ACTRN12615000152527Phase 4Completed
- Sponsor
- Hoda Alsaid Ahmed Ezz
- Start
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ferrous sulfate and epoetin alfa in Fibromyoma (LM) (3 arms), sponsored by Hoda Alsaid Ahmed Ezz. Primary endpoints: Patients receiving homologous blood transfusion and Number of homologous blood units transfused. Started Sep 2012; status: completed.
02
Drugs
ferrous sulfateepoetin alfa
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ACTRN12615000152527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000152527.